Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$781M |
| 2 |
Nike
NKE
|
+$773M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$536M |
| 4 |
Texas Instruments
TXN
|
+$493M |
| 5 |
AGN
Allergan plc
AGN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$1.07B |
| 2 |
Qualcomm
QCOM
|
+$673M |
| 3 |
TJX Companies
TJX
|
+$603M |
| 4 |
NVIDIA
NVDA
|
+$431M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Consumer Discretionary | 17.37% |
| 3 | Healthcare | 13.5% |
| 4 | Communication Services | 13.08% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
LyondellBasell Industries
LYB
$18.9B
| $601K | ﹤0.01% |
6,596
+1,081
| +20% | +$98.7K |
|
|
CBPO
602
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $574K | ﹤0.01% |
5,731
-13
| -0.2% | -$1.39K |
|
603
Credicorp
BAP
$31.1B
| $555K | ﹤0.01% |
+3,398
| New | +$559K |
|
604
Vera Bradley
VRA
$106M
| $546K | ﹤0.01% |
58,617
-5,025
| -8% | -$52.8K |
|
|
CIR
605
DELISTED
CIRCOR International, Inc
CIR
| $540K | ﹤0.01% |
9,090
-389
| -4% | -$23.9K |
|
|
FLXN
606
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $516K | ﹤0.01% |
19,174
-824
| -4% | -$16.8K |
|
|
MASI
607
DELISTED
Masimo
MASI
| $514K | ﹤0.01% |
+5,513
| New | +$454K |
|
608
Fossil Group
FOSL
$249M
| $502K | ﹤0.01% |
+28,794
| New | +$610K |
|
|
EXAS
609
DELISTED
Exact Sciences
EXAS
| $487K | ﹤0.01% |
20,627
-472
| -2% | -$9.35K |
|
610
Arbutus Biopharma
ABUS
$871M
| $455K | ﹤0.01% |
140,019
| – | – |
|
611
Steven Madden
SHOO
$3.18B
| $455K | ﹤0.01% |
+17,685
| New | +$430K |
|
|
PTHN
612
DELISTED
Patheon N.V.
PTHN
| $450K | ﹤0.01% |
+17,069
| New | +$499K |
|
|
HSNI
613
DELISTED
HSN, Inc.
HSNI
| $442K | ﹤0.01% |
11,906
-533
| -4% | -$19.1K |
|
614
Phillips 66
PSX
$83.3B
| $434K | ﹤0.01% |
5,474
-330,568
| -98% | -$26.6M |
|
615
PPG Industries
PPG
$26.4B
| $432K | ﹤0.01% |
4,113
-10,579
| -72% | -$1.07M |
|
616
Nucor
NUE
$56.4B
| $420K | ﹤0.01% |
7,041
-15,883
| -69% | -$970K |
|
|
AZPN
617
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $413K | ﹤0.01% |
7,015
-5,783
| -45% | -$340K |
|
|
HMHC
618
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $402K | ﹤0.01% |
39,655
-1,724
| -4% | -$18K |
|
619
ArcelorMittal
MT
$50.9B
| $395K | ﹤0.01% |
15,757
-33,274
| -68% | -$842K |
|
620
Lazard
LAZ
$4.23B
| $386K | ﹤0.01% |
+8,385
| New | +$362K |
|
621
Coherus Oncology
CHRS
$225M
| $383K | ﹤0.01% |
18,131
-764
| -4% | -$18.8K |
|
|
DD
622
DELISTED
Du Pont De Nemours E I
DD
| $374K | ﹤0.01% |
4,656
-21,243
| -82% | -$1.65M |
|
623
Newmont
NEM
$98.5B
| $361K | ﹤0.01% |
10,950
-25,276
| -70% | -$883K |
|
624
Power Integrations
POWI
$3.53B
| $355K | ﹤0.01% |
10,802
-552
| -5% | -$18.3K |
|
625
Penumbra
PEN
$12.6B
| $337K | ﹤0.01% |
4,037
-195
| -5% | -$14.8K |
|
Similar funds
Jennison Associates's Q1 2017 Portfolio in Review
As of Q1 2017, Jennison Associates held 861 positions worth $93.2B, up 4.1% from $89.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jennison Associates withdrew a net $4.47B in Q1 2017, closing 224 positions and reducing 376 holdings. Its most notable exit was Mobileye N.V., an estimated $165M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Snap worth $119M.
- Jennison Associates's largest Q1 2017 buy was Snap: 5,289,727 shares worth $119M.
- Jennison Associates added most to Broadcom in Q1 2017, an estimated $781M increase.
- Jennison Associates's biggest Q1 2017 reduction was Starbucks, cutting an estimated $1.07B.
- Jennison Associates fully exited Mobileye N.V. in Q1 2017, selling an estimated $165M.
- Jennison Associates's ten largest holdings make up 26% of its $93.2B portfolio in Q1 2017.
- Jennison Associates opened 55 new positions and closed 224 in Q1 2017.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $93.2B.
Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.